A Novo spokesperson said the Danish drugmaker was not ruling out further legal action after announcing new lawsuits against ...

Novo Nordisk has a commercial relationship with Economist Impact, a division of The Economist Group. The Economist operates ...

The Wilderness is the educational arm which will underpin the cultural shift needed to make the Forest of Dean sustainable in ...

The divided three-judge panel found that factual disputes remain over whether allowing teacher John Kluge to address students ...

A 3D scan of the USS Albacore’s propeller at Albacore Park sparks new STEM outreach efforts and highlights advances in marine ...

Novo Nordisk also released its second quarter results this week, boasting profit of more than $4 billion. Per-share earnings ...

COPENHAGEN (Reuters) -Novo Nordisk expects continued competition from copycat versions of its blockbuster Wegovy obesity drug ...

Novo Nordisk hit by slowing Ozempic sales, Tesla shareholders sue Musk over Robotaxi - Stock market news and latest business ...

CNBC's Karen Gilchrist discusses Wegovy-maker Novo Nordisk's efforts to regain U.S. market share amid increased competition ...

Novo Nordisk is to cut costs as the Wegovy-maker battles competition from rival Eli Lilly and copycat versions of its obesity ...

You’ll pay more for a German car or Swiss cheese, but the EU enjoys zero tariffs on American goods. That’s a bad deal. | ...

Danish pharmaceutical giant Novo Nordisk posted a sharp rise in second-quarter net profit Wednesday, but rising competition ...